STAT+: Merck discontinues a crucial antibiotic despite concerns over superbug resistance

AI Summary

Merck has discontinued Recarbio, an antibiotic used in the United States, despite concerns about resistance among superbugs. The decision raises concerns about the availability of treatments for difficult-to-treat infections.

Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.